A case of polyserositis, chylous ascites and hepatitis induced by immune checkpoint-inhibitors

Abstract

We describe a rare case of polyserositis with chylous ascites following nivolumab therapy, highlighting the challenges in recognizing and managing immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICPIs).

Keywords

• immune-related adverse events
• cancer
• immune checkpoint inhibitors
• immunotherapy